TC BioPharm Correlations
TCBPW Stock | USD 0.01 0 6.25% |
The current 90-days correlation between TC BioPharm plc and Protagenic Therapeutics is 0.03 (i.e., Significant diversification). The correlation of TC BioPharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
TC BioPharm Correlation With Market
Significant diversification
The correlation between TC BioPharm plc and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding TC BioPharm plc and DJI in the same portfolio, assuming nothing else is changed.
TCBPW |
Moving together with TCBPW Stock
Moving against TCBPW Stock
0.49 | VTRS | Viatris | PairCorr |
0.36 | BFRIW | Biofrontera Warrants | PairCorr |
0.33 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.49 | NBIX | Neurocrine Biosciences | PairCorr |
0.47 | MNMD | Mind Medicine | PairCorr |
0.44 | DXCM | DexCom Inc | PairCorr |
0.35 | MOLN | Molecular Partners | PairCorr |
0.32 | CPRX | Catalyst Pharmaceuticals | PairCorr |
Related Correlations Analysis
0.64 | 0.21 | -0.3 | -0.26 | PTIXW | ||
0.64 | 0.39 | -0.45 | -0.31 | BIAFW | ||
0.21 | 0.39 | -0.17 | 0.01 | AREBW | ||
-0.3 | -0.45 | -0.17 | 0.1 | ALVOW | ||
-0.26 | -0.31 | 0.01 | 0.1 | IINNW | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between TCBPW Stock performing well and TC BioPharm Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze TC BioPharm's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PTIXW | 18.71 | 2.67 | 0.08 | (0.56) | 18.23 | 63.74 | 159.98 | |||
BIAFW | 11.06 | (0.48) | 0.00 | 0.02 | 12.60 | 28.21 | 96.67 | |||
AREBW | 14.00 | 1.59 | 0.10 | 0.84 | 13.64 | 39.42 | 88.64 | |||
ALVOW | 5.09 | 0.35 | 0.02 | (0.47) | 5.83 | 11.80 | 38.74 | |||
IINNW | 9.31 | 0.77 | 0.06 | 0.50 | 10.53 | 20.69 | 151.39 |
TC BioPharm Corporate Management
Michael MBA | CoFounder Chairman | Profile | |
Lauren Bor | Head Division | Profile | |
Martin Thorp | CFO Director | Profile | |
Christopher Camarra | Executive Communications | Profile | |
Bryan Kobel | CEO Director | Profile | |
Angela Scott | CoFounder COO | Profile |